ghk-cu molecule Copper tripeptide (GHK-Cu) | Tripeptide Molecular structure of the tripeptide

many times the total amount a patient would receive weekly from this injection

Key characteristics include: Dual synthetic peptide formulation High-purity lyophilized research material RP-HPLC purity verification (98%) LC-MS molecular identity confirmation Suitable for peptide analytical workflows COA available for qualified production batches Batch-controlled manufacturing Consistent production quality Designed for laboratory procurement Manufacturing & Analytical Verification Research-grade BPC-157 + TB-500 is produced using Solid Phase Peptide Synthesis (SPPS), followed by chromatographic purification and analytical verification before batch release

Stopping rules: Discontinue GHK-Cu if free copper exceeds 25 mcg/dL, 24-hour urine copper exceeds 100 mcg/day, ALT or AST rises to more than 3 times the patient's baseline value, or clinical signs of copper toxicity appear

PMCID: PMC8116695

BBA-Mol Cell Biol L